Elena Capasso

611 total citations
16 papers, 386 citations indexed

About

Elena Capasso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Elena Capasso has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Hepatology. Recurrent topics in Elena Capasso's work include Cancer Treatment and Pharmacology (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Bone health and treatments (3 papers). Elena Capasso is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Bone health and treatments (3 papers). Elena Capasso collaborates with scholars based in Italy, Argentina and South Korea. Elena Capasso's co-authors include Salvatore Del Prete, Michele Caraglia, Raffaele Addeo, Liliana Montella, Vincenzo Faiola, Gregorio Cennamo, Rosario Guarrasi, Bruno Vincenzi, Giovanni Lupoli and G. Giuberti and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and BMC Cancer.

In The Last Decade

Elena Capasso

16 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Capasso Italy 10 218 134 124 106 64 16 386
Stéphane Holbrechts Belgium 9 217 1.0× 142 1.1× 112 0.9× 26 0.2× 25 0.4× 29 403
Rambha Pandey India 10 181 0.8× 71 0.5× 160 1.3× 48 0.5× 105 1.6× 50 397
Derek Leitch United Kingdom 5 433 2.0× 309 2.3× 188 1.5× 111 1.0× 110 1.7× 6 640
Jiangping Gao China 14 47 0.2× 198 1.5× 170 1.4× 80 0.8× 71 1.1× 48 459
Claudio Graiff Italy 12 166 0.8× 78 0.6× 120 1.0× 12 0.1× 55 0.9× 16 327
L. Drouard-Troalen France 7 69 0.3× 432 3.2× 44 0.4× 53 0.5× 35 0.5× 10 538
Anna Castiglione Italy 12 65 0.3× 76 0.6× 94 0.8× 86 0.8× 41 0.6× 19 366
E. Denève France 9 344 1.6× 302 2.3× 116 0.9× 18 0.2× 259 4.0× 16 687
John Theodorus Plukker Netherlands 11 131 0.6× 244 1.8× 161 1.3× 107 1.0× 26 0.4× 26 458
Mariam Jafri United Kingdom 8 64 0.3× 140 1.0× 102 0.8× 100 0.9× 124 1.9× 15 354

Countries citing papers authored by Elena Capasso

Since Specialization
Citations

This map shows the geographic impact of Elena Capasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Capasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Capasso more than expected).

Fields of papers citing papers by Elena Capasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Capasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Capasso. The network helps show where Elena Capasso may publish in the future.

Co-authorship network of co-authors of Elena Capasso

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Capasso. A scholar is included among the top collaborators of Elena Capasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Capasso. Elena Capasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Prete, Salvatore Del, Michele Caraglia, Amalia Luce, et al.. (2019). Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience. Oncology Letters. 18(4). 3873–3879. 24 indexed citations
2.
Addeo, Raffaele, Alessandro Sgambato, Gregorio Cennamo, et al.. (2010). Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 10(4). 301–306. 64 indexed citations
3.
Montella, Liliana, Raffaele Addeo, Giovannella Palmieri, et al.. (2009). Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series. Cancer Chemotherapy and Pharmacology. 65(6). 1137–1143. 20 indexed citations
4.
Montella, Liliana, Raffaele Addeo, Rosario Guarrasi, et al.. (2009). Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide. European Journal of Cancer Care. 19(2). 200–204. 9 indexed citations
5.
Montella, Liliana, Raffaele Addeo, Vincenzo Faiola, et al.. (2009). Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports. Journal of Experimental & Clinical Cancer Research. 28(1). 7–7. 7 indexed citations
6.
Addeo, Raffaele, Vincenzo Faiola, Gregorio Cennamo, et al.. (2009). A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial. Journal of Clinical Oncology. 27(15_suppl). 1085–1085. 3 indexed citations
7.
Prete, Salvatore Del, Raffaele Addeo, Michele Caraglia, et al.. (2009). 785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY. Journal of Hepatology. 50. S287–S287. 1 indexed citations
8.
Addeo, Raffaele, Vincenzo Faiola, Rosario Guarrasi, et al.. (2007). Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age. Cancer Chemotherapy and Pharmacology. 62(2). 285–292. 38 indexed citations
9.
Addeo, Raffaele, Michele Caraglia, Vincenzo Faiola, et al.. (2007). Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life. BMC Cancer. 7(1). 18–18. 61 indexed citations
10.
Prete, Salvatore Del, Raffaele Addeo, Michele Caraglia, et al.. (2007). Tailored combined treatment with radiofrequency ablation plus octreotide in advanced hepatocellular carcinoma. Journal of Clinical Oncology. 25(18_suppl). 15173–15173. 1 indexed citations
11.
Addeo, Raffaele, Vincenzo Faiola, Bruno Vincenzi, et al.. (2007). Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report. Supportive Care in Cancer. 16(2). 209–214. 10 indexed citations
12.
Gebbia, Vittorio, Salvatore Del Prete, Nicolò Borsellino, et al.. (2006). Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience. Clinical Colorectal Cancer. 5(6). 422–428. 24 indexed citations
13.
Caraglia, Michele, Raffaele Addeo, Raffaele Costanzo, et al.. (2004). Pegylated liposomal doxorubicin plus temozolamide in the salvage treatment of brain metastases: The update. Journal of Clinical Oncology. 22(14_suppl). 1576–1576. 4 indexed citations
14.
Caraglia, Michele, Raffaele Addeo, Raffaele Costanzo, et al.. (2004). Pegylated liposomal doxorubicin plus temozolamide in the salvage treatment of brain metastases: The update. Journal of Clinical Oncology. 22(14_suppl). 1576–1576. 3 indexed citations
15.
Prete, Salvatore Del, Michele Caraglia, Marc Russo, et al.. (2002). Percutaneous Ethanol Injection Efficacy in the Treatment of Large Symptomatic Thyroid Cystic Nodules: Ten-Year Follow-Up of a Large Series. Thyroid. 12(9). 815–821. 96 indexed citations
16.
Prete, Salvatore Del, Domenico Russo, Michele Caraglia, et al.. (2001). Percutaneous Ethanol Injection of Autonomous Thyroid Nodules With a Volume Larger than 40 ml: Three Years of Follow-up. Clinical Radiology. 56(11). 895–901. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026